March 12, 2018 / 10:35 AM / 3 months ago

BRIEF-Eleven Biotherapeutics Says Completed Enrollment For Late-Stage Bladder Cancer Study

March 12 (Reuters) - Eleven Biotherapeutics Inc:

* ENROLLMENT COMPLETED IN PHASE 3 REGISTRATION TRIAL FOR NON-MUSCLE INVASIVE BLADDER CANCER

* ELEVEN BIOTHERAPEUTICS INC - ‍VISTA TRIAL OF VICINIUM IN NMIBC ON-TRACK FOR TOPLINE THREE-MONTH DATA IN MID-2018​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below